Inoviq Ltd has released a press release.
Receipt of R&D Tax Incentive Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform
- 2022 Annual Report and update on results
- IIQ Investor Presentation
- IIQ Appendix 4C & Quarterly Activities Report - June 2022
- Positive SubB2M IHC Results for Melanoma
Later from Inoviq
- Canadian Patent Granted for BARD1 Technology
- IIQ Appendix 4C & Quarterly Activities Report-September 2022
- Healthcare Conference Investor Presentation
- Commercial and R&D Update
- INOVIQ Settles Legal Proceedings
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq